4.6 Article

High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer

Journal

JOURNAL OF OVARIAN RESEARCH
Volume 15, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13048-022-00986-2

Keywords

Serous ovarian cancer; Taxol resistance; RIPK2; Bioinformatics; Immune infiltration

Funding

  1. National Natural Science Foundation of China [31005808A11 12]

Ask authors/readers for more resources

This study revealed the mechanism of Taxol resistance in serous ovarian cancer, demonstrating the association between high expression of RIPK2 and Taxol resistance. RIPK2 was found to induce Taxol resistance through the activation of the NOD1/RIPK2/NF-kappa B inflammatory pathway and changes in the tumor microenvironment.
Background Taxol resistance in serous ovarian cancer is responsible for its poor prognosis, yet the underlying mechanism is still poorly understood. Thus, we probed the mechanism of Taxol resistance in serous ovarian cancer with multiple bioinformatic methods to provide novel insights into potential therapies. Methods The differentially expressed genes (DEGs) in Taxol-sensitive and Taxol-resistant cell lines and their relationship with the overall survival (OS) and progression-free interval (PFI) of ovarian cancer patients were analyzed using gene expression datasets from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). The role of receptor interacting serine/threonine kinase 2 (RIPK2) was validated via identification of its coexpressed genes, functional analysis and generation of a protein-protein interaction (PPI) network. The single sample gene set enrichment analysis (ssGSEA) was used to explore immune infiltration, and genomic alterations of RIPK2 were also analyzed via cBio Cancer Genomics Portal (cBioProtal). Results RIPK2 was highly expressed in Taxol resistant ovarian cancer cell lines, and its high expression was also linked with shorter OS and PFI in serous ovarian cancer patients. The PPI network analysis and pathway analysis demonstrated that RIPK2 might participate in the positive regulation of NF-kappa B transcription factor activity. RIPK2 expression was related to tumor microenvironment alterations, which might participate in the formation of Taxol resistance. Conclusions Our studies suggested that high expression of RIPK2 is related to Taxol resistance in serous ovarian cancer, and that RIPK2 induces Taxol resistance through NOD1/RIPK2/NF-kappa B inflammatory pathway activation and tumor microenvironment changes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available